Keywords: لانیدولول; Landiolol; Short-acting beta-blocker; Atrial fibrillation; Cardiac surgery; Systematic review;
مقالات ISI لانیدولول (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: لانیدولول; postoperative atrial fibrillation; beta-blocker; landiolol; intensive care; amiodarone
Keywords: لانیدولول; Atrial fibrillation; Landiolol; Catheter ablation; Immediate recurrence
Keywords: لانیدولول; Landiolol; Esmolol; Intraoperative supraventricular tachycardia; Efficacy; Safety
Keywords: لانیدولول; adrenergic beta-antagonists; electroconvulsive therapy; esmolol; labetalol; landiolol;
Ultra-Short-Acting β-Blockers (Esmolol and Landiolol) in the Perioperative Period and in Critically Ill Patients
Keywords: لانیدولول; ultra-short-acting; adrenergic beta-antagonists; esmolol; landiolol; perioperative period; critical care; anesthesia, intensive care;
Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
Keywords: لانیدولول; Torsade de pointes; Long-QT syndrome; β-blocker; Landiolol;
Study design for control of HEART rate in inFant and child tachyarrhythmia with heart failure Using Landiolol (HEARTFUL): A prospective, multicenter, uncontrolled clinical trial
Keywords: لانیدولول; β-Blocker; Heart failure; Landiolol; Pediatric tachyarrhythmia;
The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial
Keywords: لانیدولول; Esophagectomy; Landiolol; Atrial fibrillation; Cytokine; Arrhythmia; Tachycardia;
Practical applicability of landiolol, an ultra-short-acting β1-selective blocker, for rapid atrial and ventricular tachyarrhythmias with left ventricular dysfunction
Keywords: لانیدولول; Arrhythmias; Landiolol; β-Blockers; Heart failure; LV dysfunction
Pharmacokinetics and pharmacodynamics of two different landiolol formulations in a healthy Caucasian group
Keywords: لانیدولول; Cardioselective β-blocker; Landiolol; Sinus rhythm; Atrial fibrillation; Atrial flutter; Heart rate; Formulation;
Design of a prospective observational survey on landiolol in atrial fibrillation/atrial flutter patients with chronic heart failure – AF-CHF landiolol survey
Keywords: لانیدولول; Atrial fibrillation; β-Blocker; Landiolol; Heart failure; Long-term outcome
Continuous administration of landiolol reduced QT dispersion in postoperative patients
Keywords: لانیدولول; Antiarrhythmogenic effect; Beta blockers; Landiolol; QT dispersion
Acute hemodynamic effects of landiolol, an ultra-short-acting beta-blocker, in patients with acute coronary syndrome: Preliminary study
Keywords: لانیدولول; Landiolol; Beta-blocker; Acute coronary syndrome; Acute hemodynamic response
Determination of landiolol, an ultra-short-acting β1-receptor antagonist, in human plasma by liquid chromatography–tandem mass spectrometry
Keywords: لانیدولول; Landiolol; β1-Receptor antagonist; LC–MS/MS; Determination; Plasma
Neuroprotective effects of selective beta-1 adrenoceptor antagonists, landiolol and esmolol, on transient forebrain ischemia in rats; a dose–response study
Keywords: لانیدولول; Adrenergic beta antagonist; Esmolol; Landiolol; Forebrain ischemia
Intravenous landiolol, a novel β1-adrenergic blocker, reduces the minimum alveolar concentration of sevoflurane in women
Keywords: لانیدولول; β1-adrenergic blockers; Landiolol; Minimum alveolar concentration (MAC); Sevoflurane
Post-treatment with selective beta1 adrenoceptor antagonists provides neuroprotection against transient focal ischemia in rats
Keywords: لانیدولول; Adrenergic β antagonists; Esmolol; Landiolol; Brain ischemia; Post-treatment
Detection of landiolol using high-performance liquid chromatography/fluorescence: A blood esterase-sensitive ultra-short-acting β1-receptor antagonist
Keywords: لانیدولول; Landiolol; Ultra-short-acting β1-receptor antagonist; HPLC/fluorescence; Pseudocholinesterase; One-step solid-phase extraction
Effects of landiolol on QT interval and QT dispersion during induction of anesthesia using computerized measurement
Keywords: لانیدولول; Tracheal intubation; QT interval; Rate-corrected QT interval; QT dispersion; Rate-corrected QT dispersion; Landiolol;
Comparative effects of propofol, landiolol, and nicardipine on hemodynamic and bispectral index responses to endotracheal intubation: a prospective, randomized, double-blinded study
Keywords: لانیدولول; Antihypertensive drugs; Bispectral index monitoring; Hemodynamic stability; Intubation; Landiolol; Propofol
The effect of landiolol on hemodynamics and left ventricular function in patients with coronary artery disease
Keywords: لانیدولول; Coronary artery disease; Hemodynamics; Landiolol; Left ventricular function; Off-pump coronary artery bypass